Zürich-based health technology company building clinical AI for European primary care. The Jupiter Ecosystem connects an EHR, a patient app and Dia, an AI clinical reasoning layer: AI proposes, the physician decides. ahtida’s live digital clinic is the proprietary data engine.
Products, services, technology
Jupiter Ecosystem: Jupiter, an EHR and Clinic OS in daily clinical use; Europa, a patient app; and Dia, an AI clinical reasoning layer in development, with a physician validation gate on every output. Plus a live Swiss digital clinic offering online medical consultations and e-prescription.
Cooperation possibilities
We seek pharma partners for personalised medication and patient support, academic and clinical partners for validation studies of Dia, clinics and physician networks to pilot the Jupiter Ecosystem, and seed investors to scale across Switzerland, Greece and Germany.
Some insights
Europe is short of about one million healthcare workers while chronic disease and medication harm grow. ahtida is building AI that reasons over the full patient record, so physicians can make safer, personalised treatment decisions and stay in control of every one.
Founded in October 2025, ahtida had a regulated digital clinic with paying patients live four months later, running on our own EHR in daily use by our doctors. A lean, founder-led team, supported by Innosuisse and ZHAW, building clinical AI on real-world care rather than slides.
Strengths: European pharma leadership, full-stack engineering, and senior medical and regulatory expertise; together we built a live clinic and EHR in months. Next: a Head of AI Engineering to lead Dia, plus clinical data science and MDR quality management as we scale.
Introductions to pharma companies and Swiss hospitals for clinical validation partnerships, access to seed and Series A investors in digital health, and shared know-how on Swissmedic and MDR certification for AI software. Also visibility to attract top AI and clinical talent.
University hospitals and primary care physician networks, health insurers interested in AI-supported care models, digital health investors, and research groups at ETH, EPFL and Swiss universities working on clinical AI. Pharma medical affairs and market access teams,
